| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.64B | 5.43B | 2.96B | 4.44B | 8.78B | 2.93B |
| Gross Profit | 5.52B | 4.74B | 2.42B | 4.12B | 8.49B | 2.68B |
| EBITDA | 1.85B | 1.58B | -420.30M | 1.72B | 4.08B | 632.10M |
| Net Income | 1.26B | 1.02B | -608.40M | 1.23B | 2.97B | 348.20M |
Balance Sheet | ||||||
| Total Assets | 25.07B | 23.10B | 21.18B | 21.40B | 21.25B | 15.64B |
| Cash, Cash Equivalents and Short-Term Investments | 1.74B | 2.10B | 1.79B | 1.57B | 2.62B | 1.14B |
| Total Debt | 10.71B | 9.50B | 9.26B | 8.68B | 8.50B | 8.05B |
| Total Liabilities | 18.35B | 16.76B | 15.39B | 14.58B | 15.54B | 12.71B |
| Stockholders Equity | 6.72B | 5.61B | 5.19B | 6.22B | 5.28B | 2.69B |
Cash Flow | ||||||
| Free Cash Flow | 889.30M | -837.20M | 138.30M | -419.90M | 1.75B | -230.40M |
| Operating Cash Flow | 969.30M | -759.50M | 204.90M | -379.30M | 1.79B | -169.20M |
| Investing Cash Flow | -74.90M | -77.60M | -43.60M | -828.80M | -32.20M | -61.20M |
| Financing Cash Flow | -549.90M | 682.80M | -99.60M | 114.80M | -242.50M | 370.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $18.74B | 28.83 | 10.68% | 2.63% | -22.38% | 437.16% | |
69 Neutral | $178.68B | 42.06 | 35.17% | 3.25% | 31.91% | 19.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $48.58B | 85.07 | 13.92% | 2.88% | 45.89% | -9.53% | |
63 Neutral | $20.80B | ― | 2.55% | 3.47% | 43.48% | -24.02% | |
60 Neutral | $104.80B | 56.41 | 8.22% | 0.61% | -24.62% | -48.96% | |
47 Neutral | $7.19B | ― | -88.82% | 2.31% | 88.68% | -494.20% |
On September 19, 2025, The Carlyle Group Inc. and its subsidiaries entered into a senior notes indenture with The Bank of New York Mellon Trust Company, issuing $800 million in 5.050% Senior Notes due 2035. The notes, guaranteed by Carlyle’s subsidiaries, include covenants limiting certain corporate actions and provide for redemption options and events of default. Additionally, on September 16, 2025, Carlyle and its subsidiaries signed an underwriting agreement with several major financial institutions, ensuring the legality and issuance of the notes.
The most recent analyst rating on (CG) stock is a Buy with a $75.00 price target. To see the full list of analyst forecasts on Carlyle Group stock, see the CG Stock Forecast page.
On September 16, 2025, Carlyle Group announced the pricing of an $800 million offering of 5.050% senior notes due 2035, guaranteed by its subsidiaries. The proceeds will be used for general corporate purposes, with the offering expected to close on September 19, 2025, subject to customary conditions.
The most recent analyst rating on (CG) stock is a Sell with a $56.00 price target. To see the full list of analyst forecasts on Carlyle Group stock, see the CG Stock Forecast page.
Carlyle Group’s recent earnings call painted a picture of robust financial health and strategic growth, despite facing some hurdles in the corporate private equity market. The sentiment expressed was largely positive, highlighting the company’s strong financial performance, significant capital returns, successful fundraising endeavors, and strategic expansions.
The Carlyle Group Lp is a global investment firm specializing in private capital deployment across three main segments: Global Private Equity, Global Credit, and Carlyle AlpInvest, with a significant presence worldwide and over $465 billion in assets under management.
On July 28, 2025, Carlyle Group announced significant leadership changes effective January 1, 2026, with John C. Redett, Mark Jenkins, and Jeff Nedelman appointed as Co-Presidents. This restructuring aims to enhance Carlyle’s strategic priorities and investment performance. John Redett will oversee Global Private Equity, Mark Jenkins will lead Global Credit and Insurance, and Jeff Nedelman will continue with Global Client Business. Additionally, Justin Plouffe will succeed Redett as Chief Financial Officer. These appointments are expected to strengthen Carlyle’s market positioning and drive future growth, reflecting the firm’s commitment to evolving and delivering value to investors.
The most recent analyst rating on (CG) stock is a Sell with a $45.00 price target. To see the full list of analyst forecasts on Carlyle Group stock, see the CG Stock Forecast page.